Results

Total Results: 247 records

Showing results for "laboratory".

141. Recommendation: Human Immunodeficiency Virus (HIV) Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening
     June 11, 2019 - Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations. CDC website. … Centers for Disease Control and Prevention (CDC). 2018 Quick Reference Guide: Recommended Laboratory

142. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ph_fauqHQjmrSqPAWKrARA
     September 28, 2021 - Studies that used laboratory or imaging tests were compared with those relying only on clinical history … Setting: Excluded on the basis of setting alone (eg, emergency departments, research laboratories, worksites … Obesity and laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin.

143. Archived: Rh(D) Incompatibility: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/rhd-incompatibility-screening-1996
     January 01, 1996 - Kleihauer-Betke) is both sensitive and specific when done correctly, 1 , 36 but it is subject to substantial laboratory

144. Archived: Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2008
     December 30, 2013 - Measuring total cholesterol alone is acceptable for screening if available laboratory services cannot

145. Archived: Final Evidence Summary: Skin Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary46/skin-cancer-screening-2009
     February 15, 2009 - because of a state reporting mandate and the research team's active monitoring of dermatopathology laboratories

146. Final Recommendation Statement: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
     September 28, 2021 - factors of preeclampsia can be categorized into those obtained by medical history, clinical examination, laboratory

147. Recommendation: Genital Herpes Infection: Serologic Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/genital-herpes-serologic-screening
     February 14, 2023 - asymptomatic pregnant persons. 4 For pregnant persons with a clinical history suggestive of HSV without laboratory

148. Screening for Skin Cancer: An Update of the Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/LgBN7_z7hqynt6BRzUUYA-
     February 01, 2009 - because of a state reporting mandate and the research team’s active monitoring of dermatopathology laboratories

149. Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/efwy72cuMdhcF2jotkhTzC
     March 29, 2019 - Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations. … Centers for Disease Control and Prevention (CDC). 2018 Quick Reference Guide: Recommended Laboratory

150. Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/YALMYpRCoRSu9nhPFGudEm
     November 01, 2022 - asymptomatic pregnant persons.4 For pregnant persons with a clini- cal history suggestive of HSV without laboratory

151. JAMA (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ymZSPeLcwZ9rxTC-7zdWbp
     July 11, 2022 - factors of preeclampsia can be categorized into those obtained by medical history, clinical examination, laboratory

152. Recommendation: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
     September 28, 2021 - factors of preeclampsia can be categorized into those obtained by medical history, clinical examination, laboratory

153. Archived: Screening: Evidence Summary: Gestational Diabetes Mellitus, Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/-screening-evidence-summary/gestational-diabetes-mellitus-screening-january-2014
     May 15, 2013 - These criteria reflect changes that have occurred in laboratory glucose measurements over the years, … easier to administer to women who cannot tolerate a glucose drink, and less time-consuming for women and laboratories

154. Screening for HIV in Pregnant Women: Systematic Review to Update the 2005 USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/mTPBWPMDqfuWvodfd5R5Ms
     November 01, 2012 - Laboratory or imaging effects of antiretroviral therapy for children with uncertain clinical implications … the observational studies reports longer-term follow-up from a study included in the prior review. ‡ Laboratory

155. Archived: Screening for HIV in Pregnant Women: Evidence Summary: Human Immunodeficiency Virus (HIV) Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/screening-for-hiv-in-pregnant-women-evidence-summary/human-immunodeficiency-virus-hiv-infection-screening-2013
     November 15, 2012 - Laboratory or imaging effects of antiretroviral therapy for children with uncertain clinical implications … ‡ Laboratory markers of mitochondrial dysfunction, hematologic abnormalities, and echocardiographic

156. Archived: Evidence Summary: Sexually Transmitted Infections: Behavioral Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/sexually-transmitted-infections-behavioral-counseling-september-2014
     September 22, 2014 - concealment, blinding of outcome assessors, reliable outcome measures (for example, at least standard laboratory … The STI results were generally based on laboratory tests for bacterial infections, most commonly gonorrhea

157. Final Recommendation Statement: Hepatitis B Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/hepatitis-b-virus-infection-screening
     December 15, 2020 - risk Detection Adequate evidence that the identification of HBV infection is accurate based on laboratory-based

158. Recommendation: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing
     August 20, 2019 - et al ). 30 Previously, BRCA1/2 mutation testing in the United States was mainly conducted by 1 laboratory … Richards S, Aziz N, Bale S, et al; ACMG Laboratory Quality Assurance Committee.

159. Archived: Carotid Artery Stenosis: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/carotid-artery-stenosis-screening-july-2014
     July 08, 2014 - A good-quality meta-analysis reported wide variation in measurement properties between laboratories,

160. Final Recommendation Statement: Prevention of Child Maltreatment: Primary Care Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/child-maltreatment-primary-care-interventions
     March 19, 2024 - comprehensive medical and event history, physical examination, and further diagnostic workup (eg, imaging or laboratory